financetom
Business
financetom
/
Business
/
Kroger Finalizes $1.37 Billion US Opioid Settlement, States Say
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Kroger Finalizes $1.37 Billion US Opioid Settlement, States Say
Nov 5, 2024 8:13 PM

07:21 AM EST, 11/05/2024 (MT Newswires) -- Kroger ( KR ) has finalized a $1.37 billion settlement with a coalition of 30 state attorneys general, addressing the grocer's alleged role in the US opioid crisis, several state attorneys general announced Monday.

Kroger ( KR ) will be subject to injunctive relief that will require monitoring and sharing data related to suspicious opioid activity across its pharmacies, according to the settlement.

Under the agreement, the company agreed to pay $1.2 billion over the next 11 years, with $172.8 million in fees over the next 6 years.

Virginia expects to receive up to $29.4 million for opioid abatement as part of the settlement, while Nevada anticipates $26.7 million, according to Attorneys General Jason Miyares and Aaron Ford, respectively.

Utah Attorney General Sean Reyes said they expect around $45 million from the settlement, while North Carolina Attorney General Josh Stein said they are looking to receive $40 million.

Kroger ( KR ) did not immediately respond to MT Newswires' request for comment.

Price: 56.60, Change: +0.03, Percent Change: +0.05

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Apple to Modestly Beat Fiscal Fourth-Quarter Views, BofA Says
Apple to Modestly Beat Fiscal Fourth-Quarter Views, BofA Says
Nov 3, 2024
12:23 PM EDT, 10/25/2024 (MT Newswires) -- Apple ( AAPL ) is expected to report fiscal fourth-quarter results modestly above market estimates next week, with iPhone demand seen picking up after the launch of artificial intelligence features in late October, BofA Securities said Friday. The brokerage estimates the technology giant to report per-share earnings of $0.96 for the September quarter,...
Newell Brands Q3 Earnings: Margins Hit Highest Levels Since 2020, Boosts 2024 EPS Outlook & More
Newell Brands Q3 Earnings: Margins Hit Highest Levels Since 2020, Boosts 2024 EPS Outlook & More
Nov 3, 2024
Newell Brands Inc. ( NWL ) shares are trading higher after the company reported third-quarter financial results and raised its 2024 EPS guidance. The company reported adjusted earnings per share of 16 cents, in line with the street view. Normalized diluted earnings per share included a negative 2 cents impact associated with a company’s normalization practice change. Quarterly sales of...
Septerna valued at $970 million as shares rise nearly 31% in Nasdaq debut
Septerna valued at $970 million as shares rise nearly 31% in Nasdaq debut
Nov 3, 2024
(Reuters) -Septerna's shares rose about 31% in their market debut on Friday, giving the Goldman Sachs ( GS )-backed biotech firm a valuation of $970 million. The company's shares opened at $23.5 in their Nasdaq debut, compared with the IPO price of $18. Septerna upsized its offering twice on Thursday to sell 16 million shares, to raise $288 million. Biotech...
Ocuphire Pharma Acquires Opus Genetics
Ocuphire Pharma Acquires Opus Genetics
Nov 3, 2024
12:19 PM EDT, 10/25/2024 (MT Newswires) -- Ocuphire Pharma (OCUP) acquired Opus Genetics and the combined company will operate as Opus Genetics, the Retinal Degeneration Fund said Friday. The combined company will focus on developing gene therapies to cure genetic eye disorders and trade on the Nasdaq under the ticker IRD, the RD Fund added. Financial terms of the transaction...
Copyright 2023-2026 - www.financetom.com All Rights Reserved